TY - JOUR
T1 - Alcohol based tissue fixation as an alternative for formaldehyde
T2 - Influence on immunohistochemistry
AU - Van Essen, Hendrik F.
AU - Verdaasdonk, Marina A.M.
AU - Elshof, Sabrina M.
AU - De Weger, Roel A.
AU - van Diest, Paulus Joannes
PY - 2010/12
Y1 - 2010/12
N2 - Background: Formaldehyde is commonly used in histopathology to fix tissue. Not only are the carcinogenic properties of this solution a hazard to the people in the workplace, it is also a major burden on the environment, and it crosslinks molecular groups that hinder immunohistochemistry. Aims: The influence of two new alcohol based noncrosslinking fixatives on immunohistochemical staining properties was tested on various tissues. Methods: Fresh tissue samples were cut into three equal pieces, which were then fixed in the alcohol based fixatives Boonfix or RCL2, or in neutral buffered formaldehyde (NBF) as control. After fixation, tissue was routinely processed to paraffin sections. Deparaffinised slides were blocked for endogenous peroxidase and subsequently submitted to the usual NBF based immunohistochemical protocols for 85 different common antibodies either not requiring antigen retrieval (AR), or AR in citrate buffer, EDTA or pepsin. Results: NBF fixed tissues provided significantly better immunostaining results (84% good staining) than RCL2 (66% good) and Boonfix (60%). The lesser performance of RCL2 and Boonfix was especially caused by pepsin AR which caused significant tissue damage. Omission of pepsin AR resulted in better immunostaining for these antibodies for RCL2 fixed tissues which were overall no longer significantly worse than NBF fixed tissue. Conclusion: Tissues fixed in non-crosslinking alcohol based fixatives can successfully be immunohistochemically stained for most antibodies following the usual NBF based protocols. Omission of pepsin pretreatment seems to be important to retain proper morphology of immunostained tissues preserved in alcohol based fixatives. Therefore, when switching to less toxic and non-carcinogenic alcohol-based fixatives like RCL2, no major changes in the daily routine of immunohistochemistry are anticipated.
AB - Background: Formaldehyde is commonly used in histopathology to fix tissue. Not only are the carcinogenic properties of this solution a hazard to the people in the workplace, it is also a major burden on the environment, and it crosslinks molecular groups that hinder immunohistochemistry. Aims: The influence of two new alcohol based noncrosslinking fixatives on immunohistochemical staining properties was tested on various tissues. Methods: Fresh tissue samples were cut into three equal pieces, which were then fixed in the alcohol based fixatives Boonfix or RCL2, or in neutral buffered formaldehyde (NBF) as control. After fixation, tissue was routinely processed to paraffin sections. Deparaffinised slides were blocked for endogenous peroxidase and subsequently submitted to the usual NBF based immunohistochemical protocols for 85 different common antibodies either not requiring antigen retrieval (AR), or AR in citrate buffer, EDTA or pepsin. Results: NBF fixed tissues provided significantly better immunostaining results (84% good staining) than RCL2 (66% good) and Boonfix (60%). The lesser performance of RCL2 and Boonfix was especially caused by pepsin AR which caused significant tissue damage. Omission of pepsin AR resulted in better immunostaining for these antibodies for RCL2 fixed tissues which were overall no longer significantly worse than NBF fixed tissue. Conclusion: Tissues fixed in non-crosslinking alcohol based fixatives can successfully be immunohistochemically stained for most antibodies following the usual NBF based protocols. Omission of pepsin pretreatment seems to be important to retain proper morphology of immunostained tissues preserved in alcohol based fixatives. Therefore, when switching to less toxic and non-carcinogenic alcohol-based fixatives like RCL2, no major changes in the daily routine of immunohistochemistry are anticipated.
UR - http://www.scopus.com/inward/record.url?scp=78649636359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649636359&partnerID=8YFLogxK
U2 - 10.1136/jcp.2010.079905
DO - 10.1136/jcp.2010.079905
M3 - Article
C2 - 20978021
AN - SCOPUS:78649636359
SN - 0021-9746
VL - 63
SP - 1090
EP - 1094
JO - Journal of clinical pathology
JF - Journal of clinical pathology
IS - 12
ER -